Furthermore, the parallel eNOS down-regulation observed exclusively in SHRSP over lifetime, consistent with reduced PPARα expression [20], may also contribute, through decreased nitric oxide production, to promote both hypertension and vascular damage in SHRSP. The gene discussed is PPARA; the disease is Hypertension.